Michał Kuliński

1.0k total citations
19 papers, 624 citations indexed

About

Michał Kuliński is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michał Kuliński has authored 19 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Michał Kuliński's work include Cancer-related Molecular Pathways (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Ubiquitin and proteasome pathways (3 papers). Michał Kuliński is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Ubiquitin and proteasome pathways (3 papers). Michał Kuliński collaborates with scholars based in Qatar, United States and United Kingdom. Michał Kuliński's co-authors include Shahab Uddin, Kirti S. Prabhu, Said Dermime, Anna Halama, Kodappully Sivaraman Siveen, Martin Steinhoff, Abdul Quaiyoom Khan, Roopesh Krishnankutty, Ajaz A. Bhat and Karsten Suhre and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Michał Kuliński

19 papers receiving 617 citations

Peers

Countries citing papers authored by Michał Kuliński

Since Specialization

Citations

This map shows the geographic impact of Michał Kuliński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Kuliński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Kuliński more than expected).

Fields of papers citing papers by Michał Kuliński

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Kuliński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Kuliński. The network helps show where Michał Kuliński may publish in the future.

Co-authorship network of co-authors of Michał Kuliński

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Kuliński. A scholar is included among the top collaborators of Michał Kuliński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Kuliński. Michał Kuliński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection 2021 ·Scientific Reports ·Satanay Hubrack, Maryam Al‐Nesf, (unknown), Christophe M. Raynaud, (unknown), (unknown), (unknown), (unknown), Said Dermime, Maysaloun Merhi, Michał Kuliński, Martin Steinhoff, Patrick Tang, Bernice Lo	10
2	Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway 2021 ·Biomedicine & Pharmacotherapy ·Kirti S. Prabhu, Ajaz A. Bhat, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, Syed Shadab Raza, (unknown), (unknown), Abdul Quaiyoom Khan, (unknown), Mohammad Haris, Michał Kuliński, Said Dermime, Martin Steinhoff, Shahab Uddin	42
3	Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin 2020 ·Frontiers in Oncology ·Lubna Therachiyil, (unknown), (unknown), Kodappully Sivaraman Siveen, Shahab Uddin, Michał Kuliński, Joerg Buddenkotte, Martin Steinhoff, Roopesh Krishnankutty	18
4	Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases 2020 ·Seminars in Cancer Biology ·Abdul Quaiyoom Khan, Fareed Ahmad, Syed Shadab Raza, Lubna Zarif, Kodappully Sivaraman Siveen, (unknown), Maha Victor Agha, Khalid Rashid, Michał Kuliński, Joerg Buddenkotte, Shahab Uddin, Martin Steinhoff	29
5	Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications 2020 ·Seminars in Cancer Biology ·(unknown), (unknown), Abdul Quaiyoom Khan, Kirti S. Prabhu, Afsheen Raza, Michał Kuliński, Said Dermime, Mohammad Haris, Kulsoom Junejo, Shahab Uddin	55
6	The metabolic footprint of compromised insulin sensitivity under fasting and hyperinsulinemic-euglycemic clamp conditions in an Arab population 2020 ·Scientific Reports ·Anna Halama, Noor Suleiman, Michał Kuliński, Ilham Bettahi, (unknown), (unknown), (unknown), Ahmad Iskandarani, (unknown), Stephen L. Atkin, Karsten Suhre, Abdul‐Badi Abou‐Samra	5
7	Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway 2020 ·International Journal of Molecular Sciences ·Abdul Quaiyoom Khan, Eiman I. Ahmed, (unknown), (unknown), Kirti S. Prabhu, Kodappully Sivaraman Siveen, Michał Kuliński, Fouad Azizi, Said Dermime, Aamir Ahmad, Martin Steinhoff, Shahab Uddin	77
8	Prevalence and Type Distribution of High-Risk Human Papillomavirus (HPV) in Breast Cancer: A Qatar Based Study 2020 ·Cancers ·(unknown), (unknown), Michał Kuliński, (unknown), Vinod Kumar Gupta, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giles Davies, Said Dermime, Shahab Uddin, G. Hossein Ashrafi, Kulsoom Junejo	28
9	Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells 2020 ·Cancers ·Kirti S. Prabhu, Afsheen Raza, Thasni Karedath, Syed Shadab Raza, (unknown), Eiman I. Ahmed, Shilpa Kuttikrishnan, Lubna Therachiyil, Michał Kuliński, Said Dermime, Kulsoom Junejo, Martin Steinhoff, Shahab Uddin	31
10	Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma 2020 ·International Journal of Molecular Sciences ·Sabah Akhtar, Tayyiba Akbar Ali, (unknown), Omar S. Khan, Syed Shadab Raza, Michał Kuliński, Halima El Omri, Ajaz A. Bhat, Shahab Uddin	25
11	Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS 2019 ·Frontiers in Endocrinology ·Anna Halama, Myint Myint Aye, Soha R. Dargham, Michał Kuliński, Karsten Suhre, Stephen L. Atkin	37
12	Protein Expression Profiling Identifies Key Proteins and Pathways Involved in Growth Inhibitory Effects Exerted by Guggulsterone in Human Colorectal Cancer Cells 2019 ·Cancers ·(unknown), Lubna Therachiyil, (unknown), Shahab Uddin, Michał Kuliński, Joerg Buddenkotte, Martin Steinhoff, Roopesh Krishnankutty	17
13	Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis 2018 ·Cancer Letters ·Anna Halama, Michał Kuliński, (unknown), Shaza B. Zaghlool, Kodappully Sivaraman Siveen, Ahmad Iskandarani, Jonas Zierer, Kirti S. Prabhu, (unknown), Aditya Bhagwat, Shahab Uddin, Gabi Kastenmüller, Olivier Elemento, Steven S. Gross, Karsten Suhre	58
14	Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells 2017 ·PLoS ONE ·Kirti S. Prabhu, Kodappully Sivaraman Siveen, Shilpa Kuttikrishnan, Ahmad Iskandarani, (unknown), Iman W. Achkar, Lubna Therachiyil, Roopesh Krishnankutty, Aijaz Parray, Michał Kuliński, Maysaloun Merhi, Said Dermime, Ramzi M. Mohammad, Shahab Uddin	35
15	Dysregulated expression of SKP2 and its role in hematological malignancies 2017 ·Leukemia & lymphoma ·Michał Kuliński, Iman W. Achkar, Mohammad Haris, Said Dermime, Ramzi M. Mohammad, Shahab Uddin	14
16	Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells 2016 ·Journal of Translational Medicine ·Ahmad Iskandarani, Ajaz A. Bhat, Kodappully Sivaraman Siveen, Kirti S. Prabhu, Shilpa Kuttikrishnan, Muzammil Ahmad Khan, Roopesh Krishnankutty, Michał Kuliński, Rihab Nasr, Ramzi M. Mohammad, Shahab Uddin	30
17	Measurement of 1,5-anhydroglucitol in blood and saliva: from non-targeted metabolomics to biochemical assay 2016 ·Journal of Translational Medicine ·Anna Halama, Michał Kuliński, Sara Abdul Kader, (unknown), Abdul‐Badi Abou‐Samra, Karsten Suhre, Ramzi M. Mohammad	33
18	Involvement of F-BOX proteins in progression and development of human malignancies 2015 ·Seminars in Cancer Biology ·Shahab Uddin, Ajaz A. Bhat, Roopesh Krishnankutty, Fayaz Ahmad Mir, Michał Kuliński, Ramzi M. Mohammad	44
19	Polymer-based non-viral gene delivery as a concept for the treatment of cancer 2009 ·Pharmacological Reports ·Anna Halama, Michał Kuliński, Tadeusz Librowski, Stanisław Lochyński	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact